EmbeddingGemma 2: an open, lightweight multimodal embedding model
deepmind.google·6d ago
AI Engineering
Hacker News·Jul 23·5 min read
Couple pay >$800k for a gene-editing therapy for their daughter. She died.
TL;DR
A couple spent over $800,000 on a gene-editing therapy for their daughter, who tragically passed away despite the treatment. This raises critical questions about the efficacy and accessibility of such advanced medical interventions.
✦ Why It Matters
Evaluate the risks and benefits of gene-editing therapies before making healthcare decisions.
Key Takeaways
- Research the success rates of gene-editing therapies before investing.
- Consider emotional and financial implications of advanced medical treatments.
- Stay informed about the latest developments in genetic therapies.
- Engage with healthcare professionals to understand treatment options.
Full Summary
Gene-editing therapies, such as CRISPR, have emerged as revolutionary treatments for genetic disorders. In this case, a couple invested more than $800,000 in a gene-editing therapy aimed at curing their daughter's condition.
Unfortunately, despite the high hopes and financial investment, the therapy did not save her life, leading to her untimely death. This incident highlights the potential risks and limitations associated with cutting-edge medical technologies, particularly in terms of their effectiveness and the emotional toll on families.
The case also underscores the need for clearer communication regarding the success rates and potential outcomes of such therapies. As gene-editing becomes more prevalent, understanding its implications for patients and families is crucial.